- Home
- CISS vs NDRA Comparison
CISS vs NDRA Comparison
Compare CISS & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- NDRA
- Stock Information
- Founded
- CISS 2022
- NDRA 2007
- Country
- CISS Greece
- NDRA United States
- Employees
- CISS N/A
- NDRA N/A
- Industry
- CISS Marine Transportation
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CISS Consumer Discretionary
- NDRA Health Care
- Exchange
- CISS Nasdaq
- NDRA Nasdaq
- Market Cap
- CISS 2.8M
- NDRA 2.3M
- IPO Year
- CISS N/A
- NDRA 2017
- Fundamental
- Price
- CISS $3.56
- NDRA $3.36
- Analyst Decision
- CISS
- NDRA Strong Buy
- Analyst Count
- CISS 0
- NDRA 1
- Target Price
- CISS N/A
- NDRA $46.00
- AVG Volume (30 Days)
- CISS 20.6K
- NDRA 97.6K
- Earning Date
- CISS 05-15-2025
- NDRA 05-15-2025
- Dividend Yield
- CISS N/A
- NDRA N/A
- EPS Growth
- CISS N/A
- NDRA N/A
- EPS
- CISS N/A
- NDRA N/A
- Revenue
- CISS $38,174,754.00
- NDRA N/A
- Revenue This Year
- CISS N/A
- NDRA N/A
- Revenue Next Year
- CISS N/A
- NDRA N/A
- P/E Ratio
- CISS N/A
- NDRA N/A
- Revenue Growth
- CISS N/A
- NDRA N/A
- 52 Week Low
- CISS $2.85
- NDRA $2.90
- 52 Week High
- CISS $25.35
- NDRA $286.48
- Technical
- Relative Strength Index (RSI)
- CISS 43.43
- NDRA 44.40
- Support Level
- CISS $3.55
- NDRA $3.31
- Resistance Level
- CISS $3.83
- NDRA $3.80
- Average True Range (ATR)
- CISS 0.17
- NDRA 0.26
- MACD
- CISS -0.00
- NDRA 0.04
- Stochastic Oscillator
- CISS 1.59
- NDRA 50.28
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.